Cargando…

Clinical relevance of systemic monocytic-MDSCs in patients with metastatic breast cancer

The overall aim of this prospective study was to delineate the role of monocytic myeloid-derived suppressor cells (Mo-MDSCs) in patients with metastatic breast cancer (MBC). MDSCs are a heterogeneous group of immunosuppressive cells often enriched in different malignancies which hold prognostic and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bergenfelz, Caroline, Roxå, Anna, Mehmeti, Meliha, Leandersson, Karin, Larsson, Anna-Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044142/ https://www.ncbi.nlm.nih.gov/pubmed/31925475 http://dx.doi.org/10.1007/s00262-019-02472-z

Ejemplares similares

Impact of systemic therapy on circulating leukocyte populations in patients with metastatic breast cancer
por: Larsson, Anna-Maria, et al.
Publicado: (2019)

Systemic Monocytic-MDSCs Are Generated from Monocytes and Correlate with Disease Progression in Breast Cancer Patients
por: Bergenfelz, Caroline, et al.
Publicado: (2015)

Human G-MDSCs are neutrophils at distinct maturation stages promoting tumor growth in breast cancer
por: Mehmeti-Ajradini, Meliha, et al.
Publicado: (2020)

S100A9 expressed in ER(−)PgR(−) breast cancers induces inflammatory cytokines and is associated with an impaired overall survival
por: Bergenfelz, Caroline, et al.
Publicado: (2015)

Peripheral Blood Mononuclear Cell Populations Correlate with Outcome in Patients with Metastatic Breast Cancer
por: Larsson, Anna-Maria, et al.
Publicado: (2022)

Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer
por: Mehmeti, Meliha, et al.
Publicado: (2015)

Wnt5a is a TLR2/4-ligand that induces tolerance in human myeloid cells
por: Mehmeti, Meliha, et al.
Publicado: (2019)

The Generation and Identity of Human Myeloid-Derived Suppressor Cells
por: Bergenfelz, Caroline, et al.
Publicado: (2020)

Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers
por: Allaoui, Roni, et al.
Publicado: (2016)

On the origin of myeloid-derived suppressor cells
por: Millrud, Camilla Rydberg, et al.
Publicado: (2016)

Increased circulating monocyte MDSCs positively correlate with serum Interleukin-10 in metastatic melanoma patients
por: Mirjačić Martinović, Katarina, et al.
Publicado: (2023)

Serum immuno-oncology markers carry independent prognostic information in patients with newly diagnosed metastatic breast cancer, from a prospective observational study
por: Gunnarsdottir, Frida Björk, et al.
Publicado: (2023)

Clinical Relevance and Immunosuppressive Pattern of Circulating and Infiltrating Subsets of Myeloid-Derived Suppressor Cells (MDSCs) in Epithelial Ovarian Cancer
por: Okła, Karolina, et al.
Publicado: (2019)

Identification of monocyte-like precursors of granulocytes in cancer as a mechanism for accumulation of PMN-MDSCs
por: Mastio, Jérôme, et al.
Publicado: (2019)

MDSCs: Key Criminals of Tumor Pre-metastatic Niche Formation
por: Wang, Yungang, et al.
Publicado: (2019)

Prognostic stromal gene signatures in breast cancer
por: Winslow, Sofia, et al.
Publicado: (2015)

Regulation of PMP22 mRNA by G3BP1 affects cell proliferation in breast cancer cells
por: Winslow, Sofia, et al.
Publicado: (2013)

Complement inhibitor factor H expressed by breast cancer cells differentiates CD14(+) human monocytes into immunosuppressive macrophages
por: Smolag, Karolina I., et al.
Publicado: (2020)

Monocytic MDSCs homing to thymus contribute to age-related CD8(+) T cell tolerance of HBV
por: Fang, Zhong, et al.
Publicado: (2022)

Stroke-Induced Modulation of Myeloid-Derived Suppressor Cells (MDSCs) and IL-10-Producing Regulatory Monocytes
por: Achmus, Lennart, et al.
Publicado: (2020)

Induction of M-MDSCs with IL6/GM-CSF from adherence monocytes and inhibition by WP1066
por: Hu, Hao, et al.
Publicado: (2022)

Monocytic MDSCs exhibit superior immune suppression via adenosine and depletion of adenosine improves efficacy of immunotherapy
por: Sarkar, Omar S., et al.
Publicado: (2023)

The clinical impact of tumour‐infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: A cohort study
por: Berntsson, Jonna, et al.
Publicado: (2017)

WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells
por: Ekström, Elin J, et al.
Publicado: (2014)

MIF inhibition reverts the gene expression profile of human melanoma cell line-induced MDSCs to normal monocytes
por: Waigel, Sabine, et al.
Publicado: (2016)

MDSCs in breast cancer: an important enabler of tumor progression and an emerging therapeutic target
por: Liu, Haoyu, et al.
Publicado: (2023)

Improving cancer immunotherapy by targeting the STATe of MDSCs
por: de Haas, Nienke, et al.
Publicado: (2016)

Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma
por: de Coaña, Yago Pico, et al.
Publicado: (2017)

The Effect of Immunosuppressive Drugs on MDSCs in Transplantation
por: Yang, Fan, et al.
Publicado: (2018)

Immunotherapy of targeting MDSCs in tumor microenvironment
por: Sui, Hongshu, et al.
Publicado: (2022)

Accumulation of blood-circulating PD-L1-expressing M-MDSCs and monocytes/macrophages in pretreatment ovarian cancer patients is associated with soluble PD-L1
por: Okła, Karolina, et al.
Publicado: (2020)

Pre-diagnostic anthropometry, sex, and risk of colorectal cancer according to tumor immune cell composition
por: Berntsson, Jonna, et al.
Publicado: (2019)

Expression of programmed cell death protein 1 (PD-1) and its ligand PD-L1 in colorectal cancer: Relationship with sidedness and prognosis
por: Berntsson, Jonna, et al.
Publicado: (2018)

Chronic psychological stress promotes breast cancer pre-metastatic niche formation by mobilizing splenic MDSCs via TAM/CXCL1 signaling
por: Zheng, Yifeng, et al.
Publicado: (2023)

Correction to: Accumulation of blood-circulating PD-L1-expressing M-MDSCs and monocytes/macrophages in pretreatment ovarian cancer patients is associated with soluble PD-L1
por: Okła, Karolina, et al.
Publicado: (2020)

The STAT3 inhibitor galiellalactone inhibits the generation of MDSC‐like monocytes by prostate cancer cells and decreases immunosuppressive and tumorigenic factors
por: Hellsten, Rebecka, et al.
Publicado: (2019)

Inhibition of CCL7 derived from Mo-MDSCs prevents metastatic progression from latency in colorectal cancer
por: Ren, Xiaoli, et al.
Publicado: (2021)

New roles of Rb1 in expansion of MDSCs in cancer
por: Youn, Je-In, et al.
Publicado: (2013)

High frequency of myeloid-derived suppressor cells in sepsis patients, with the granulocytic subtype dominating in Gram-positive cases
por: Janols, H, et al.
Publicado: (2014)

Catechins and antitumor immunity: Not MDSC’s cup of tea
por: Santilli, Giorgia, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_49sm3hoarsbls6iqfdqo59v5c6